165 related articles for article (PubMed ID: 8447843)
1. New basic esters of 2-phenyl-3-methyl-4-oxo-4H-1-benzopyran-8-carboxylic acid endowed with spasmolytic properties. Synthesis and pharmacological-pharmacokinetic evaluation.
Nardi D; Leonardi A; Pennini R; Tajana A; Cazzulani P; Testa R
Arzneimittelforschung; 1993 Jan; 43(1):28-34. PubMed ID: 8447843
[TBL] [Abstract][Full Text] [Related]
2. Effects of terflavoxate on stimulated contractions of urinary bladder in vitro.
Testa R; Guarneri L; Bernasconi P; Angelico P; Ibba M; Poggesi E; Meli A
Arzneimittelforschung; 1993 Feb; 43(2):122-8. PubMed ID: 8384453
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and pharmacological properties of alkyl esters of various DL-omega-phenylamino acids].
Schulz E; Sprung WD; Kröning G
Pharmazie; 1983 May; 38(5):310-3. PubMed ID: 6611626
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of various spasmolytic drugs on isolated human and porcine detrusor smooth muscle.
Uckert S; Stief CG; Odenthal KP; Becker AJ; Truss MC; Jonas U
Arzneimittelforschung; 1998 Aug; 48(8):836-9. PubMed ID: 9748713
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmaceutical activity of new series of chromonyl derivatives.
Fawzy NM; Swelam SA; Batran SA
Boll Chim Farm; 2004; 143(1):24-33. PubMed ID: 15085572
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of terflavoxate.
Leonardi A; Cappelletti R; Nardi D; Giordano F
Arzneimittelforschung; 1993 Mar; 43(3):356-62. PubMed ID: 8489568
[TBL] [Abstract][Full Text] [Related]
7. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activities of the main metabolite of flavoxate 3-methylflavone-8-carboxylic acid.
Cazzulani P; Pietra C; Abbiati GA; Ceserani R; Oliva D; Civelli M; Tajana A; Nardi D
Arzneimittelforschung; 1988 Mar; 38(3):379-82. PubMed ID: 2838033
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
[TBL] [Abstract][Full Text] [Related]
10. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
[TBL] [Abstract][Full Text] [Related]
11. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological screening of few new 2-(substituted acetyl) amino-5-alkyl-1,3,4-oxadiazoles.
Mishra P; Joshi GK; Shakya AK; Agrawal RK; Patnaik GK
Indian J Physiol Pharmacol; 1992 Oct; 36(4):247-50. PubMed ID: 1291476
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and their enantiomers with those of racemic terodiline.
Smith ER; Wright SE; Aberg G; Fang Y; McCullough JR
Arzneimittelforschung; 1998 Oct; 48(10):1012-8. PubMed ID: 9825119
[TBL] [Abstract][Full Text] [Related]
15. Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity.
Pochet L; Doucet C; Schynts M; Thierry N; Boggetto N; Pirotte B; Jiang KY; Masereel B; de Tullio P; Delarge J; Reboud-Ravaux M
J Med Chem; 1996 Jun; 39(13):2579-85. PubMed ID: 8691456
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of benzopyran analogues bearing class III antiarrhythmic pharmacophores.
Koufaki M; Kiziridi C; Papazafiri P; Vassilopoulos A; Varró A; Nagy Z; Farkas A; Makriyannis A
Bioorg Med Chem; 2006 Oct; 14(19):6666-78. PubMed ID: 16782345
[TBL] [Abstract][Full Text] [Related]
17. Antispasmodic effects of flavoxate, MFCA, and REC 15/2053 on smooth muscle of human prostate and urinary bladder.
Caine M; Gin S; Pietra C; Ruffmann R
Urology; 1991 Apr; 37(4):390-4. PubMed ID: 2014611
[TBL] [Abstract][Full Text] [Related]
18. [Search for new spasmolytic derivatives of 1,3-diaminoisopropyl diphenylacetate].
Graczyk J; Kamińska A; Szadowska A; Tkaczyński T; Urbańska A
Acta Pol Pharm; 1976; 33(2):145-5. PubMed ID: 937018
[No Abstract] [Full Text] [Related]
19. Synthesis and anticholinergic properties of some N,N-disubstituted carbamodithioic acid 2-oxo-2-(phenylamino)ethyl esters.
Caliş U; Ozkanli F; Dalkara S; Erol K; Ozdemir M
Pharmazie; 1993 Dec; 48(12):945-6. PubMed ID: 8115441
[No Abstract] [Full Text] [Related]
20. Some pharmacological properties of perhydro-1,4-thiazepine and perhydro-1,2,5-dithiazepine derivatives.
Strzelczyk M; Matyjewska H; Strózyński H
Pol J Pharmacol Pharm; 1990; 42(4):377-85. PubMed ID: 1982963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
